Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Judy Staffa

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Archives of Internal Medicine|September 17, 2002
Concurrent use of selected agents with moxifloxacin: an examination of labeling compliance within 1 year of marketingAllen Brinker, Judy Staffa
JAMA Internal Medicine|May 5, 2020
Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy ProgramDoris Auth, Judy Staffa, Cynthia LaCivita
Pharmacoepidemiology and Drug Safety|January 5, 2008
Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysisMara McAdams, Judy Staffa, Gerald Dal Pan
Pharmacoepidemiology and Drug Safety|September 18, 2018
Commentary on "Methodologic limitations of prescription opioid safety research and recommendations for improving the evidence base"Judy Staffa, Tamra Meyer, Alex Secora, et al.
JAMA Pediatrics|September 10, 2016
Effect of US Food and Drug Administration-Approved Pediatric Labeling on Dispensing of Extended-Release Oxycodone in the Outpatient Retail SettingJing Xu, Rajdeep Gill, Marisa Cruz, et al.
Pain|October 6, 2020
Patterns of opioid analgesic use in the U.S., 2009 to 2018Corinne Woods, Grace Chai, Tamra Meyer, et al.
Pediatrics|June 20, 2012
Trends of outpatient prescription drug utilization in US children, 2002-2010Grace Chai, Laura Governale, Ann W McMahon, et al.
Pharmacoepidemiology and Drug Safety|January 8, 2014
Drug risk assessment and data reuseSolomon Iyasu, Judy Staffa, Dave Graham, et al.
Pharmacoepidemiology and Drug Safety|January 1, 2009
Emergency department visits attributed to selected analgesics, United States, 2004-2005Mary Willy, Judith P Kelly, Parivash Nourjah, et al.
Pharmacoepidemiology and Drug Safety|December 16, 2017
Opioid analgesic dose and the risk of misuse, overdose, and death: A narrative reviewDavid Tyler Coyle, Chih-Ying Pratt, Josephine Ocran-Appiah, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Archives of Internal Medicine|September 17, 2002
Concurrent use of selected agents with moxifloxacin: an examination of labeling compliance within 1 year of marketingAllen Brinker, Judy Staffa
JAMA Internal Medicine|May 5, 2020
Assessing the Opioid Analgesic Risk Evaluation and Mitigation Strategy ProgramDoris Auth, Judy Staffa, Cynthia LaCivita
Pharmacoepidemiology and Drug Safety|January 5, 2008
Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysisMara McAdams, Judy Staffa, Gerald Dal Pan
Pharmacoepidemiology and Drug Safety|September 18, 2018
Commentary on "Methodologic limitations of prescription opioid safety research and recommendations for improving the evidence base"Judy Staffa, Tamra Meyer, Alex Secora, et al.
JAMA Pediatrics|September 10, 2016
Effect of US Food and Drug Administration-Approved Pediatric Labeling on Dispensing of Extended-Release Oxycodone in the Outpatient Retail SettingJing Xu, Rajdeep Gill, Marisa Cruz, et al.
Pain|October 6, 2020
Patterns of opioid analgesic use in the U.S., 2009 to 2018Corinne Woods, Grace Chai, Tamra Meyer, et al.
Pediatrics|June 20, 2012
Trends of outpatient prescription drug utilization in US children, 2002-2010Grace Chai, Laura Governale, Ann W McMahon, et al.
Pharmacoepidemiology and Drug Safety|January 8, 2014
Drug risk assessment and data reuseSolomon Iyasu, Judy Staffa, Dave Graham, et al.
Pharmacoepidemiology and Drug Safety|January 1, 2009
Emergency department visits attributed to selected analgesics, United States, 2004-2005Mary Willy, Judith P Kelly, Parivash Nourjah, et al.
Pharmacoepidemiology and Drug Safety|December 16, 2017
Opioid analgesic dose and the risk of misuse, overdose, and death: A narrative reviewDavid Tyler Coyle, Chih-Ying Pratt, Josephine Ocran-Appiah, et al.
Pageof 2